Selective GC receptor agonists and modulators and GC plus hydroxysteroid dehydrogenase inhibitor combination therapy are some ...

According to the team of researchers, semaglutide, which is the active ingredient in weight loss drugs Ozempic and Wegovy, ...

A matched cohort study involving 16,827 patients found that semaglutide (in drugs such as Ozempic) was associated with an ...

A pivotal clinical trial found an increased risk for worsening diabetic retinopathy with semaglutide, but a large database ...

A team from Harvard University started looking into the possible link after three people taking semaglutide – the active ...

FROM the breathless coverage 'miracle' weight-loss jabs Wegovy and Ozempic have had so far, you'd be forgiven for thinking ...

Now, there’s a new one to add to the mix: Semaglutide is linked with a rare form of vision loss called non-arteritic anterior ...

But the Mayo Clinic ophthalmologist who presented the findings stressed that it was “hugely reassuring” the GLP-1s were ...

Dr. Joseph Rizzo, director of the Neuro-Ophthalmology Service at Mass Eye and Ear, noticed some of his group’s patients who ...

People taking semaglutide may have a higher risk of developing a rare "eye stroke" that can result in vision loss. Diabetes, ...